Infants undergo extensive developments during their first year of life. Although the biological mechanisms involved are not yet fully understood, changes in the DNA methylation in mammals are believed to play a key role. This study was designed to investigate changes in infant DNA methylation that occurs between 6 and 52 weeks. A total of 214 infant saliva samples from 6 or 52 weeks were assessed using principal component analyses and t-distributed stochastic neighbor-embedding algorithms. Between the two time points, there were clear differences in DNA methylation. To further investigate these findings, paired two-sided student's t-tests were performed. Differently methylated regions were defined as at least two consecutive probes that showed significant differences, with a q-value < 0.01 and a mean difference > 0.2. After correcting for false discovery rates, changes in the DNA methylation levels were found in 42 genes. Of these, 36 genes showed increased and six decreased DNA methylation. The overall DNA methylation changes indicated decreased gene expression. This was surprising because infants undergo such profound developments during their first year of life. The results were evaluated by taking into consideration the extensive development that occurs during pregnancy. During the first year of life, infants have an overall three-fold increase in weight, while the fetus develops from a single cell into a viable infant in 9 months, with an 875-million-fold increase in weight. It is possible that the findings represent a biological slowing mechanism in response to extensive fetal development. In conclusion, our study provides evidence of DNA methylation changes during the first year of life, representing a possible biological slowing mechanism. We encourage future studies of DNA methylation changes in infants to replicate the findings by using a repeated measures model and less stringent criteria to see if the same genes can be found, as well as investigating whether other genes are involved in development during this period.
In the first year of life, profound changes take place in human physical and neurodevelopmental functioning 1 . Infants learn to sit, stand up, walk, and say their first words 2 . This rapid growth occurs in an orderly and regulated sequence, laying the building blocks for future growth 1 . Although infant developmental milestones are well-known 2 , the underlying biological mechanisms driving this development in the first year of life are not yet fully understood. Epigenetics is believed to play an important role in mediating the developmental changes in mammalian development 3 , but to the best of our knowledge, few studies have been published specifically on the epigenetic role in infant development.
Here, DNA methylation is one type of epigenetic mechanism that regulates gene expression without altering the DNA sequence 4 ; it is involved in many cellular processes and is known to be relatively stable. However, DNA methylation might change within an individual over time 5 . Embryonic and pluripotent stem cell DNA methylation is close to zero 6 but changes extensively from fertilization to implantation 7 . Children from 2 to 16 years of age have been found to have increased levels of the age-related gene DNA methylation, with the greatest changes being found early, from 2 to 10 years of age 8 .
Two age-specific epigenetic occurrences have been studied: epigenetic drift 9 and the epigenetic clock 6, 10 . Epigenetic drift relates to the changes in DNA methylation over time, which differs among individuals 11 . Examples can be found in twin DNA methylation studies that find that DNA methylation differences increase over time in relation to age and different lifestyles 9, 12 . The epigenetic clock, which was conceived by Horvath 6 and Hannum 13 , is a means to calculate a person's epigenetic age based on DNA methylation calculated from age-related CpG sites. Studies of age-related DNA methylation changes have mainly been of older populations, which are confounded by Participants. A subsample of 172 infants from the "Little in Norway" study 18 was used for the current study;
for the experiment, 274 saliva samples from infants 6 weeks old (n = 62), 52 weeks old (n = 30), or both (n = 61) were selected. The sociodemographic variables are shown in Table 1 . The saliva samples were collected using the Oragene DNA assisted collection kit (OG-575) (DNA Genotek, 2018). Quality control (QC) and cell composition analyses removed 60 saliva samples, leaving 214 saliva samples from 153 infants for epigenetic analyses. The infants' mothers volunteered information about their age, education level, and marital status. Data on fetal gender were collected from birth records. Saliva samples and DNA methylation profiling. The 274 infant saliva samples were collected at 6 and 52 weeks using the OG-575 assisted collection kit. DNA methylation profiling was conducted at the Norwegian Sequencing Centre using the Infinium Human Methylation 450 K BeadChip array (Illumina, San Diego, CA, USA). DNA extraction was conducted using the Oragene prep-IT.L2P kit (DNA Genotek, Ottawa, ON, Canada), and the quantity was assessed using PicoGreen (Thermo Fisher, Waltham, MA, USA). The EZ-96 DNA Methylation-Gold Kit (Zymo Research) was used for the bisulfite conversion of 320-500 ng of the saliva DNA samples.
The DNA samples were randomly located on 96-well plates to minimize potential batch effects, and beta-mixture quantile normalization (BMIQ) was used to normalize the β-values 19 . During QC, 29,233 cross-reactive probes 20 , 4,232 probes with single nucleotide polymorphisms (SNPs) at the CpG site, 16,819 probes and 13 samples with unreliable measurements (detection p-values > 0.01), 9,675 probes located on the sex chromosomes, and 2,303 non-CpG probes were removed. In total, 18 samples were removed, leaving 256 for cell composition assessment.
Cell composition. Because the human body consists of over 250 different cell types and the epigenome is highly variable between these cell types 21 , various analyses of infant saliva cell composition were conducted. Previous research has shown that leukocytes and epithelial cells are both found in saliva samples that come from the oral cavities of children (mean age = 6.7 years) 22 , but to the best of our knowledge, no research has been done on infant saliva cellularity. To assess cellular composition, a small subsample of saliva samples (n = 8) from 6-week-old infants were examined under a microscope. The results showed platelet epithelial cells and bacteria, no immune cells, but as this was only a performed at 6 weeks on a small sample, leucocytes in the samples could not be excluded, the amount of leukocytes in all saliva samples was calculated using the leukocytes methylation for purity (LUMP) analysis 23 ; the results showed that 42 of the 256 samples contained > 10% leukocytes. These DNA samples were excluded from the analyses. This choice of cutoff was made to exclude outliers, while keeping as may samples as possible. In total, 42 samples were removed, leaving 214 samples for the analyses.
Computational analyses. Sociodemographic data analyses were performed using SPSS version 25 (IBM, SPSS Statistics, New York, NY, USA). The raw methylation data preprocessing was done with RnBeads v.1.2.1 24 using the R programming language (http://www.r-project.org/). The methylation analysis was performed using MATLAB R2017B (The MathWorks Inc., Natick, MA, USA), and principal component analyses (PCA) were performed using Evince (Prediktera AB, Umeå, Sweden). All statistical tests were done using two-sided student's t-tests, assuming unequal variance, and any false discovery was corrected (q-value) 25 . Changes in differentially methylated regions (DMR) between 6 and 52 weeks were defined using the following criteria: q-value < 0.01, mean difference between groups > 0.2, and a minimum Figure 1 . Sample scatter plots The sample-to-sample scatter plots display an anticipated cigar-like shape, indicating that the methylation levels for most probes are similar. The left two panels were generated using the same subject, with 6 weeks being displayed on the X-axis and 52 weeks on the Y-axis. The color indicates the probe density. These density plots show no large-scale methylation differences based on the time points, here with 6 weeks shown in blue and 52 weeks shown in red, but there is linear behavior, with most of the probes being located close to the diagonal. There is an increased number of probes that are differently methylated, that is, located far from the diagonal, indicating individual-specific methylation patterns that vary between the infants. 
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Epigenetic disease associations
Intracellular processes ARHGEF7 (β-PIX) + Body Cytoskeletal organization 61, 62 Intracellular processes CLU − TSS1500 Apoptosis inhibitor 29 Alzheimer's disease 63 showed that there was minimal heterogeneity in methylation among the cell types assayed and that the methylation levels were more similar for the two time points for a single infant than between infants, as shown in Fig. 1 , indicating that the samples were well suited for DNA methylation analyses. The distribution of the beta values across all the samples shows a clear bi-modal distribution, as shown in Fig. 2 , which indicates minimal heterogeneity in methylation among the cell types assayed. 
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Unsupervised dimensional reduction analyses show separation between time points. The
DNA methylation changes in infants between 6 and 52 weeks were analyzed using two separate algorithms (PCA) and t-distributed stochastic neighbor embedding (t-SNE), which are both agnostic to grouping issues. PCA is well-known algorithm used to investigate differences in data, while t-SNE is a newer, nonlinear dimensionality reduction algorithm that investigates the similarities in data 28 . The two different unsupervised dimensional reduction methods were applied to the samples using all 423,315 probes. Both algorithmic plots showed clear separations between the two time points, as shown in Fig. 3A,B . For PCA, the first three components showed clear separations between the two time points, as shown in Fig. 3A , and the algorithm gave similar results for t-SNE, as shown in Fig. 3B . These results indicate that there is a consistent time point difference and that this difference is greater than the individual differences.
Statistically significant DNA methylation changes found in 42 genes. Stringent analytical crite-
ria were selected to avoid discovering false DNA methylation sites because this was the first time that analyses have been performed to investigate DNA methylation changes for this population. Statistically significant DMRs were found in 42 genes in a total of 101 (out of 423,315) probes. The distribution of the probes within each gene showed consistent increases or decreases in methylation. A total of 36 genes showed increased methylation, and six showed decreased methylation. See Supplementary Table S1 for a detailed description of the results.
Decreased DNA methylation was associated with only 6 genes. In total, six genes had decreased DNA methylation. CLU 29 and XAF1 30 are apoptosis inhibitors, ORAOV1 regulates the cell cycle and apoptosis 31 , PAQR7 regulates progesterone receptors 32 , and EIF4E3 promotes messenger RNA transport and proliferation 33 , while RTP4 has largely unknown functions.
Increased DNA methylation associated with systemic biological processes. Change to 'Of the 42 genes found to have statistically significant changes in DNA methylation, 13 genes that are associated with intracellular processes. The detailed results for these genes and their associated intracellular functions are presented in Table 2 . Of the remaining genes, 24 were previously described as being associated with systemic biological functions 34 and all were found to have increased methylation. The genes and associated systemic functions are presented in Table 3 ' .
MCHR1. The melanin-concentrating hormone receptor 1 (MCHR1) gene is an example of one of the genes with increased DNA methylation from 6 to 52 weeks. MCHR1 has nine probes on the Illumina Infinium HumanMethylation450 BeadChip array. In these analyses, the results showed increased DNA methylation at two CpG sites: the 1st exon and the body. The mean DNA methylation increase for the two sites had an Δβ value of 0.21. DNA methylation changes in this gene have been associated with schizophrenia 34 and bipolar disorder 35 . The changes in DNA methylation in the CpG site for the 1st exon, cg21342728, found in the current study, were described in the study of schizophrenia 34 . The DNA methylation changes for MCHR1 are shown in Fig. 4 .
SLC1A2. The solute carrier family 1 member 2 (SLC1A2) gene is another example of a gene with increased DNA methylation from 6 to 52 weeks. This gene has been found to have DNA methylation differences associated with schizophrenia and bipolar disorder 36 and prematurity in infants 37 . It has 32 probes on the Illumina Infinium www.nature.com/scientificreports www.nature.com/scientificreports/ HumanMethylation450 BeadChip array. The analyses showed a significant increase in methylation in the first three adjacent CpG sites in the promoter region (TSS1500) from 6 to 52 weeks. The mean DNA methylation increase of the three sites had an Δβ value of 0.29, and the largest difference was found at cg10159951, with a mean DNA methylation at 6 weeks of 0.12 and at 52 weeks of 0.45. The DNA methylation difference in the CpG site of the promoter island, cg25963980, has previously been associated with DNA methylation changes associated with infant prematurity 37 . The DNA methylation changes for SLC1A2 are shown in Fig. 5 . The left Y-axis shows the genomic coordinates for each probe, while the right Y-axis displays the probe Id. The CpG column to the right indicates the CpG island and the gene column in the gene body where the probe is from. For each probe, the methylation level is illustrated by a box plot, where the box is the interquartile range, and the median is the dot for the 6-week group (blue) and the 52week group (red). Significant probes are shown with * for q < 0.01 and difference > 0.2 and ** for q < 0.001 and difference > 0.3. The significant methylation probes for SLC1A2 are located in the promoter area (TSS1500).
Discussion
To the best of our knowledge, we conducted the first EWAS using Illumina450K analyses of infant saliva samples to study DNA methylation changes between 6 and 52 weeks of age. Two very different and unsupervised dimensionality algorithms-PCA and t-SNE-were used in the current study. The results showed clear separations between infant DNA methylation at the two studied time points. The greatest consistent difference is the time point and nonindividual differences. Because both the PCA and t-SNE showed the same separation in infant DNA methylation between the two time points, the findings indicate that the biological mechanisms associated with normal infant development in the first year of life are associated with DNA methylation changes.
To better understand which genes were associated with these changes, we analyzed the DNA methylation further and found that there were 42 genes across 101 probes with statistically significant DNA methylation changes. Of the 42 genes, 36 had increased DNA methylation, and six had decreased methylation levels. The effect of DNA methylation depends on where it occurs in the gene, and the DNA methylation changes in the current study occurred in different parts of the genes but most commonly were associated with decreased gene expression 17 .
The suggested decreased gene expression was unexpected as infants experience rapid developmental growth during the first year of life. However, infant development in the first year of life is relatively limited compared with the changes that occur during pregnancy 38 . The fetus develops from a single cell to a viable infant in 9 months, with an 875-million-fold increase in weight 39, 40 ; meanwhile, during the first year of life, the infant only experiences a three-fold increase in weight 2 . Therefore, although our findings are limited to buccal epithelial cells, they suggest a biological growth-slowing mechanism post-birth after the rapid fetal growth during pregnancy.
Our study has several strengths and limitations that need to be considered when interpreting the results. One important limitation for DNA methylation analyses is cell composition. It would have been better if the saliva sample at both 6 weeks and 52 weeks had been assessed. To compensate for this, LUMP scores were calculated for all saliva samples, finding leucocytes in the samples and using a cutoff of 10% for the analyses. However, if possible, further studies should consider assessing sample cell composition from all time points included in the analyses. Other limitations of the current study were that the population was made up of an overrepresentation of mothers with a high level of education compared with the general Norwegian population, and the study did not compare the characteristics of the whole "Little in Norway" cohort with the sample analyzed in the current study to assess selection bias and understand whether the findings are generalizable to the whole population.
One of the major strengths of the current study was that the saliva samples came from two time points, but still, these results cannot answer the question of whether DNA methylation fluctuates over the first year or if there is only an overall increase in DNA methylation. Therefore, to assess this, future studies should consider collecting more than two saliva samples over the first year of life. Another major strength was that the current study was based on the methodology used in cancer research because this field is at the forefront of epigenetic research, and human biology is the same for both cancer and biological development. Applying cutting-edge bioinformatical methods 28 used in cancer research to examine biological mechanisms, 42 genes were found to have DNA methylation changes associated with early-life biological development. Of these, 14 had previously been found in different forms of cancers associated with epigenetic changes [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] , yet here, only two studies found epigenetic associations with development 37, 59 . This might be because these genes are all associated with cancer, but it is just as likely that more cancer research is being conducted because of public and political efforts that increase cancer research funding.
The bioinformatic analysis of the epigenetic data commonly includes a determination of the significant differences at a single CpG site, considering them independently of each other and adjusting for false discovery rates 60 . Because this was the first study to investigate DNA methylation changes between 6 and 52 weeks, we wanted to avoid false positive results; therefore, we set stricter criteria for the significance of DMRs than what has been commonly used. If we had used other criteria, other significant DNA methylation changes would have been identified, but we wanted all of the discovered CpG sites to be correct and the probability of false positive findings to be small. Using this analytical model, we found 42 CpG sites with infant DNA methylation changes, but different analytical models for the analyses could reveal different results. Our choice of analytical method limited the possibility of correcting for confounders, such as gender. Future analyses should consider choosing a repeated measures model, so confounding variables can be adjusted for, this way confounding variables such as gender should be addressed. Hence, we encourage future studies of DNA methylation changes in infants to replicate the findings by using a repeated measures model and less stringent criteria to see if the same genes can be found, as well as investigating whether other genes are involved in development during this period.
conclusion
In conclusion, the algorithmic analyses showed that infant DNA methylation displays clear differences between 6 and 52 weeks. To investigate these differences further, two-sided student's t-tests were performed. These analyses found 42 genes associated with DNA methylation changes. Of these, 36 genes showed increased and six decreased DNA methylation. The methylation changes indicated an overall decrease in gene expression, which, in turn, might represent a slowing mechanism to reduce the extensive growth development that occurs during pregnancy. Future studies of DNA methylation changes in infants could use repeated measures models and less stringent criteria to see if the same genes can be replicated, and whether other genes are involved in development during this period.
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